Treatment of acid-related disorders, including erosive esophagitis, gastric ulcer, duodenal ulcer, prevention of recurrence of gastric or duodenal ulcers during low-dose aspirin or nonsteroidal anti-inflammatory drug (NSAID) therapy, and eradication of Helicobacter pylori infection; adjunctive therapy for conditions associated with Helicobacter pylori infection, such as gastric MALT lymphoma, idiopathic thrombocytopenic purpura, early gastric cancer, and Helicobacter pylori-associated gastritis.